Seastar Medical Holding Corp Receivables Turnover Ratio (ICU), from the second quarter 2026 to the second quarter 2025 current and historic results, rankings and more - CSIMarket
CSIMarket
 


Seastar Medical Holding Corp  (NASDAQ: ICU)
 

Seastar Medical Holding Accounts Receivables Turnover Ratio from the second quarter 2026 to the second quarter 2025

Quarterly Results, Trends, Rankings, Statistics


Seastar Medical Holding Corp's ability to collect its outstanding accounts receivable from its corporate clients, has improved in the second quarter 2026 to a ratio of 8.11, this represents a new company high. This is a clear indication for improving liquidity at Seastar Medical Holding Corp's clients. Average receivable collection period, for the Seastar Medical Holding in Jun 30 2026 quarter, has decreased to 45 days, compared to 54 days, in the Mar 31 2026 quarter.

If we take a look into Healthcare sector 158 other companies have achieved higher receivables turnover ratio. While receivables turnover ratio total ranking has improved thus far to 1954, from overall ranking in the first quarter 2026 at 2435.

What is Receivable Turnover Ratio?
What is Seastar Medical Holding Corp Selling?


What is Receivable Turnover Ratio?





ICU Receivables Turnover Ratio (Jun 30 2026)
II. Quarter
(Mar 31 2026)
I. Quarter
(Dec 31 2025)
IV. Quarter
(Sep 30 2025)
III. Quarter
(Jun 30 2025)
II. Quarter
Y / Y Receivable Change -4.15 % 62.73 % 111.61 % 225 % -
Y / Y Revenue Change 81.95 % 68.94 % 526.87 % 169.12 % -
Receivable Turnover Ratio (TTM) 8.11 6.73 6.29 5.34 6.04
ICU's Total Ranking # 1954 # 2435 # 2613 # 2345 #
Accounts Receivable average collection period days 45 54 58 68 60
Seq. Receivable Change 16.2 % -24.47 % 7.24 % 1.84 % 97.27 %
Seq. Revenue Change 24.24 % 17.86 % 129.51 % -45.86 % 15.36 %


Receivable Turnover Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 48
Healthcare Sector # 159
Overall Market # 1954

Receivable Turnover Ratio Statistics
High Average Low
8.11 6.5 5.34
(Jun 30 2026)   (Sep 30 2025)






Financial Statements
Seastar Medical Holding's Accounts Receivable $ 0 Millions Visit ICU's Balance sheet
Seastar Medical Holding's Sales TTM $ 2 Millions Visit ICU's Income Statement
Sources of ICU's Revenues Visit ICU's Sales by Geography

Other Accounts Receivable Turnover Ratios
Medical Equipment & Supplies Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
ICU's Receivable Turnover Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
ICU's Growth Rates ICU's Roa ICU's Inventory Turnover Ratio ICU's Dividend Comparisons
ICU's Profitability Ratios ICU's Roi ICU's Asset Turnover Ratio ICU's Dividend Growth
ICU's Valuation Ratios ICU's Roe ICU's Financial Strength Ratios ICU's Dividend Payout Ratio



Companies with similar Receivables Turnover Ratio for the quarter ending Jun 30 2026, within Healthcare Sector Receivable Turnover Ratio Revenues for 12 Months ending Jun 30 2026 Receivable at quarter ending Jun 30 2026
Sonida Senior Living Inc   22.59 $ 525.973  Millions$ 23.283  Millions
U S Physical Therapy Inc  22.40 $ 812.203  Millions$ 36.251  Millions
Hims and Hers Health Inc   19.65 $ 2,578.494  Millions$ 131.228  Millions
Lipocine Inc   18.36 $ 1.569  Millions$ 0.085  Millions
Nrx Pharmaceuticals Inc   17.25 $ 3.394  Millions$ 0.197  Millions
Polomar Health Services, Inc.  17.19 $ 3.172  Millions$ 0.185  Millions
Anika Therapeutics Inc   16.70 $ 121.370  Millions$ 7.266  Millions
Vireo Growth Inc.  16.69 $ 511.706  Millions$ 30.659  Millions
Agenus Inc  15.44 $ 132.693  Millions$ 8.595  Millions
Longeveron Inc   15.03 $ 1.187  Millions$ 0.079  Millions
Medicinova Inc   15.02 $ 0.920  Millions$ 0.061  Millions
Dar Bioscience Inc   14.57 $ 1.345  Millions$ 0.092  Millions
Nexgel Inc   14.52 $ 11.810  Millions$ 0.813  Millions
China Pharma Holdings Inc  14.46 $ 3.914  Millions$ 0.271  Millions
Lftd Partners Inc   14.13 $ 35.335  Millions$ 2.500  Millions
Arvinas Inc   13.49 $ 316.700  Millions$ 23.475  Millions
Corcept Therapeutics Inc  13.30 $ 830.813  Millions$ 62.477  Millions
Precipio inc   13.25 $ 27.198  Millions$ 2.052  Millions
Chemed Corporation  12.94 $ 2,595.001  Millions$ 200.565  Millions
Qhslab Inc   12.77 $ 3.017  Millions$ 0.236  Millions
Petvivo Holdings Inc   12.34 $ 1.182  Millions$ 0.096  Millions
Alpha Pro Tech Ltd   12.25 $ 62.204  Millions$ 5.077  Millions
Vivos Therapeutics Inc   12.21 $ 21.135  Millions$ 1.731  Millions
Milestone Scientific Inc   11.82 $ 8.855  Millions$ 0.749  Millions
Marpai Inc  11.71 $ 16.635  Millions$ 1.420  Millions
Catheter Precision Inc   11.62 $ 1.915  Millions$ 0.165  Millions
Nrc Health  11.35 $ 139.996  Millions$ 12.337  Millions
Picard Medical Inc   11.34 $ 5.983  Millions$ 0.528  Millions
Veracyte Inc   11.07 $ 544.735  Millions$ 49.194  Millions
International Stem Cell Corporation  10.91 $ 9.514  Millions$ 0.872  Millions

Date modified: 2026-09-03T23:49:57+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.